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1H, 15N, and 13C Chemical Shift Assignments of the Regulatory 
Domain of Human Calcineurin
Dinesh K. Yadav1, Sri Ramya Tata1, John Hunt1, Erik C. Cook2, Trevor P. Creamer2, and 
Nicholas C. Fitzkee1
1Department of Chemistry, Mississippi State University
2Center for Structural Biology, Department of Molecular and Cellular Biochemistry, University of 
Kentucky
Abstract
Calcineurin (CaN) plays an important role in T-cell activation, cardiac system development and 
nervous system function. Previous studies have demonstrated that the regulatory domain (RD) of 
CaN binds calmodulin (CaM) towards the N-terminal end. Calcium-loaded CaM activates the 
serine/threonine phosphatase activity of CaN by binding to the RD, although the mechanistic 
details of this interaction remain unclear. It is thought that CaM binding at the RD displaces the 
auto-inhibitory domain (AID) from the active site of CaN, activating phosphatase activity. In the 
absence of calcium-loaded CaM, the RD is disordered, and binding of CaM induces folding in the 
RD. In order to provide mechanistic detail about the Ca…aN interaction, we have undertaken an 
NMR study of the RD of CaN. Complete 13C, 15N and 1H assignments of the RD of CaN were 
obtained using solution NMR spectroscopy. The backbone of RD has been assigned using a 
combination of 13C-detected CON-IPAP experiments as well as traditional HNCO, HNCA, 
HNCOCA and HNCACB-based 3D NMR spectroscopy. A 15N-resolved TOCSY experiment has 
been used to assign Hα and Hβ chemical shifts.
Keywords
Calcineurin; Intrinsically Disordered Protein; Calmodulin Binding
Biological Context
Calcineurin (CaN), also known as protein phosphatase 2B, is a Ca2+ and calmodulin (CaM)-
dependent serine/threonine phosphatase protein (Wang and Desai 1976). CaN participates in 
various roles associated with cardiac, vascular, and nervous system development, making 
CaN-mediated signaling very important for learning and memory, skeletal muscle growth, 
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and immune system activation (Rusnak and Mertz 2000). Because of its roles in these 
signaling pathways, dysregulation of CaN has been implicated in many pathological states, 
e.g. Alzheimer’s disease (Ermak and Davies 2013), Down syndrome (Hoeffer, Dey et al. 
2007), and cardiac hypertrophy (Vega, Bassel-Duby et al. 2003). CaN has the ability to 
dephosphorylate and activate the nuclear factor of activated T-cells (NFAT). NFAT proteins 
are a family of transcription factors that activate genes involved in immune response 
(Macian 2005). CaN is therefore an important target for immunosuppressant drugs like 
cyclosporin A (CspA) and FK506 (Liu, Farmer et al. 1991).
CaN is a heterodimer consisting of a 60-kDa A chain and a 19-kDa B chain. There are three 
isoforms of the CaN A chain: the α-isoform (the dominant form in neurons), the β-isoform 
(broadly distributed) and the testis-specific γ-isoform (Rusnak and Mertz 2000). The CaN A 
chain consists of the catalytic domain, the B-chain binding domain, the regulatory domain 
(RD, residues 388–458), the autoinhibitory domain (AID), and a short C-terminal tail 
(Hubbard and Klee 1989). The B chain is homologous to CaM and binds four calcium ions 
(Stemmer and Klee 1994). The AID keeps CaN in an inactive state at low concentrations of 
Ca2+, but at increased levels, CaM binds calcium and then binds to the calmodulin-binding 
region (CaMBR) of CaN, located in the RD. In the absence of calcium-loaded CaM, the RD 
is disordered (Manalan and Klee 1983, Yang and Klee 2000, Rumi-Masante, Rusinga et al. 
2012). Binding of CaM to CaN causes a structural ordering in the RD that removes the AID 
from the catalytic site of CaN, thereby activating the enzyme (Shen, Li et al. 2008, Dunlap, 
Cook et al. 2013, Dunlap, Guo et al. 2014, Zhao, Yang et al. 2014).
Several three-dimensional structures of CaN have been obtained at high resolution by X-ray 
diffraction methods as a means of understanding its catalytic mechanism. The original 
structure included residues 21–372 of CaN complexed with the inhibitory compound FK506 
(Griffith, Kim et al. 1995). Subsequent work has investigated CaN bound to cyclosporin A 
(Jin and Harrison 2002), and a solution NMR structure has been obtained for the catalytic 
domain of CaN bound to an NFAT-derived PVIVIT peptide (Takeuchi, Sun et al. 2015). The 
structure of the CaM-CaN complex is of high interest (Ye, Wang et al. 2008, Ye, Feng et al. 
2013, Dunlap, Guo et al. 2014); however, no structure to date has been obtained that 
includes the complete CaN RD. Here, we present backbone and side-chain assignments of 
the RD of CaN (residues 388–468) in the solution phase, obtained using 2D and 3D NMR 
techniques. The chemical shifts support a largely disordered conformation, although 
secondary shifts suggest that some helical propensity may be present in the RD in the 
absence of Ca2+-loaded CaM.
Methods and Experiments
RD Expression and Purification
The calmodulin-containing pETCaMI plasmid, and the RD-containing pETRD plasmid were 
co-transformed into Escherichia coli BL21(Star) DE3 competent cells (Invitrogen) for 
expression. In this system, the Human Calcineurin A domain (Isoform 1) RD protein 
sequence (residues 388–468) is flanked by three residues on the N-terminus (MAG) and a C-
terminal Histidine tag (GWGGGLEHHH HHH). For simplicity, the first three residues 
(385–387) and the C-terminal Histidine tag residues (469–481) are numbered as part of the 
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sequence, even though they are not part of the wild-type RD domain. The total RD 
construct, containing 97 residues, corresponds to constructs used previously for the study of 
the RD, and purification proceeded as described previously (Dunlap, Cook et al. 2013, 
Dunlap, Guo et al. 2014). Transformed cells were incubated in 100 ml terrific broth (TB; 12 
g/L tryptone, 24 g/L yeast extract, 4.0 ml glycerol, 0.17 M KH2PO4, 0.72 M K2HPO4, 75 
μg/ml ampicillin and 50 μg/ml kanamycin) overnight at 37°C. These starter cultures were 
then added to 1L of M9 minimal media (containing 75 μg/ml ampicillin and 50 μg/ml 
kanamycin). The starter culture in TB was used to inoculate the M9 media such that the 
initial OD600 was 0.05. This larger culture was incubated at 37°C in a 200 rpm shaker. When 
the culture reached an OD600 of 0.6–0.7, expression was induced with a final concentration 
of 1mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and harvested after 4 hours (OD600 
≈ 1.6). These cells were pelleted by centrifugation for 30 minutes at 8,000 × g, and then re-
suspended in lysis buffer (20mM HEPES pH 7.5, 200 mM NaCl, 0.1mM PMSF, 125μg/ml 
lysozyme). One tablet of Roche Complete EDTA-free protease inhibitor was added to the 
lysis buffer, and the re-suspended cells were sonicated on ice in a Branson Sonifier 250 at 
power level 6 for 3 repetitions of a 2 minute pulse/2 minute rest. Processed lysate was 
centrifuged at 18,000 × g for 45 minutes at 4°C, with CaN remaining in the soluble fraction. 
The CaN RD was purified on a Ni-NTA column (GE Life Sciences) using urea-thiourea 
buffer to separate the co-expressed CaM protein from the RD. The Ni-NTA column was 
equilibrated with 5 column volumes (CV) of 7M urea/thiourea buffer (10mM HEPES pH 
7.5, 200mM NaCl, 2M thiourea, 5M urea) at room temperature. Centrifuged lysate mixed 
with 3X volume of urea/thiourea buffer for 10 minutes and then applied to the Ni-NTA 
column. The urea/thiourea concentration was reduced to zero by washing the column with 
binding buffer (20mM HEPES pH 7.5, 200mM NaCl). The protein was eluted with 20mM 
HEPES pH 7.5, 200mM NaCl, 2mM CaCl2 and 250mM imidazole. Eluted protein was 
mixed with 50ml of column buffer (20mM HEPES pH 7.5, 200mM NaCl, 2mM CaCl2). 
Final purification was performed with a CaM-Sepharose column (GE Life Sciences) 
equilibrated with 5 CV of column buffer. Protein was eluted with a gradient from 0 – 100% 
elution buffer (20mM Tris pH 7.5, 200mM NaCl, 2mM EGTA) and pooled protein fractions 
(where the absorbance at 280 nm was higher than at 260 nm) were dialyzed in dialysis 
buffer (20 mM PIPES pH 5.5, 10 mM DTT and 100 mM NaCl) overnight and stored at 4°C. 
The molecular weight and purity of the 97-residue CaN RD were confirmed by LC-MS and 
SDS-PAGE.
NMR Spectroscopy
All samples for NMR experiments were prepared in 20mM PIPES (pH 5.5), 100 mM NaCl, 
6% D2O and 10 mM DTT. Protein concentrations ranged from 0.2 to 0.25 mM for all NMR 
experiments in a total volume of 550 μL. The samples were transferred into 5 mm NMR 
sample tubes and stored at 4°C until required for NMR experiments. All the NMR 
experiments were performed on a Bruker AVANCE III 600 MHz spectrometer, equipped 
with a multinuclear biomolecular (QCI) cryo-probe. All NMR spectra were acquired at 288 
K using Bruker TopSpin software. Experimental spectra were processed with NMRPipe 
(Delaglio, Grzesiek et al. 1995). Processed NMR spectra were assigned and visualized using 
Sparky.
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Protein backbone assignments were made using 3D HNCO, HNCA, HNCOCA 
CACBCONH, CBCANH and [1H-15N]-HSQC experiments (Grzesiek and Bax 1992). Side 
chain 1H and 13C assignments were obtained using a 3D TOCSY-HSQC and 3D 
HCCCONH spectra (Schleucher, Schwendinger et al. 1994, Carlomagno, Maurer et al. 
1996). While the initial amide-proton resolved experiments were promising, spectral overlap 
and crowding precluded the complete assignment using 15N-HSQC resolved experiments. In 
addition, the CaN RD contains three proline residues which are not detected in these spectra. 
Therefore, we also recorded an (HACA)N(CA)CON NMR experiment, which was 
instrumental in determining the complete backbone trace for this protein (Bastidas, Gibbs et 
al. 2015).
Assignments and Data Deposition
Complete backbone and side-chain 13C and 15N chemical shift assignments of RD CaN are 
presented here, and these assignments will provide insight into this disordered region of 
CaN. A 2D 1H-15N HSQC spectrum of the RD construct (residues 388–468, plus flanking 
residues), with assignments of the amide backbone, is shown (Fig. 1A). The chemical shifts 
of RD CaN have been deposited in the Biological Magnetic Resonance Data Bank (http://
www.bmrb.wisc.edu) under the accession number 26990. The 2D and 3D NMR spectra 
enabled the detection of the backbone and aliphatic side-chain resonances for the CaN RD. 
In the absence of calcium loaded CaM, the RD is fully disordered, and chemical shifts 
exhibit sharp lines and narrow dispersion in the 1H dimension (Fig. 1A), a characteristic 
typical of intrinsically disordered proteins (IDPs). Almost all non-proline residues in the 
construct have been assigned, except residues 385–387 (part of the N-terminal, non-RD 
flanking region), and residue R397 (likely because of spectral overlap). In addition, all three 
proline residues have been assigned in the CON-resolved spectra (Fig. 1B). Backbone 
sequential assignment was achieved for 95% of the amide resonances, 98% and 88% of 
the 13Cα and 13Cβ resonances respectively, and 97% of the 13CO resonances. Sets of signals 
originating from the non-RD flanking regions were more challenging to assign, likely 
because of elevated hydrogen exchange near the N-terminus (Bai, Milne et al. 1993) and 
degeneracy in the Histidine tag near the C-terminus.
Deviations from random coil chemical shifts are indicative of transiently-formed structure in 
intrinsically disordered proteins. Sequence-dependent random coil shifts have been corrected 
for pH and temperature and suggest weak structural preferences in the RD (Kjaergaard, 
Brander et al. 2011). For example, 13Cα chemical shifts (Fig. 2A) indicate a slight 
propensity for helix formation between residues 417–422 and 452–460, consistent with 
previous findings that indicate these regions adopt a helical conformation when bound to 
Calmodulin (Manalan and Klee 1983, Dunlap, Guo et al. 2014). This propensity, however, is 
not borne out by 13Cβ chemical shifts (Fig. 2B), which are quite random throughout the 
sequence. Secondary structure propensity (SSP) scores (Marsh, Singh et al. 2006) and δ2D 
population predictions (Camilloni, De Simone et al. 2012) are also consistent with a highly 
disordered RD (Fig. 2C, 2D), although a weak helical score is observed for residues 417–
422 and 452–460. The scores suggest less structural bias than has been observed in other 
IDPs, for example in the helical region of the ALS-related protein TDP-43 (Conicella, Zerze 
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et al. 2016). NMR assignments of the RD CaN will be valuable for future studies of CaN 
activation and its interaction with many target proteins.
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Figure 1. 
Assigned [1H-15N]-HSQC spectrum (A) and (HACA)N(CA)CON spectrum (B) of CaN RD 
in solution. All three proline residues in panel B are aliased.
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Figure 2. 
13Cα (A) and 13Cβ (B) secondary chemical shifts for the CaN RD. Secondary 13Cα shifts 
suggest a slight propensity for helix formation between residues 417–422 and 452–460. SSP 
scores (C) for the RD are also weakly helical in these regions. δ2D-predicted secondary 
structure propensities (D) based on experimental RD chemical shifts confirm that the RD 
overall is highly disordered. Secondary structure classifications for δ2D are designated in 
the legend.
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